APA (7th ed.) Citation

Xu, H., Xu, H., Ma, K., Ma, K., Ma, Z., Ma, Z., . . . Lin, L. Iguratimod improves bleomycin-induced pulmonary inflammation and fibrosis by regulating macrophage polarization through inhibiting the TLR4/NF-κB pathway. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Xu, Huan, et al. Iguratimod Improves Bleomycin-induced Pulmonary Inflammation and Fibrosis by Regulating Macrophage Polarization Through Inhibiting the TLR4/NF-κB Pathway. Frontiers Media S.A.

MLA (9th ed.) Citation

Xu, Huan, et al. Iguratimod Improves Bleomycin-induced Pulmonary Inflammation and Fibrosis by Regulating Macrophage Polarization Through Inhibiting the TLR4/NF-κB Pathway. Frontiers Media S.A.

Warning: These citations may not always be 100% accurate.